Shanghai Haoyuan Chemexpress Co., Ltd.

Shanghai Stock Exchange 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 5.02%

Shanghai Haoyuan Chemexpress Co., Ltd. Return on Capital Employed (ROCE) is 5.02% for the year ending December 31, 2023, a -36.97% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Shanghai Haoyuan Chemexpress Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 7.96%, a -26.49% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 10.83%, a -59.85% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 26.97%, a 30.91% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 20.60%, a 53.66% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

Shanghai Stock Exchange: 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd.

CEO	Mr. Baofu Zheng
IPO Date	June 8, 2021
Location	China
Headquarters	No. 3 Building, No. 1999
Employees	3,370
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Key trends

Past 5 years